VRDN Viridian Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
19:20
May 11
May 11
r/wallstreetbets
Institutions bought shares at $17.00 in an upsized offering and are locked from selling until.
Institutions bought shares at $17.00 in an upsized offering and are locked from selling until $26; stock currently trades at $16.89. This creates a “floor” below the offering price, and the June 30 PDUFA for veligrotug is a binary catalyst that could send the stock to $34+. Buy the dip below institutional entry; the setup offers both downside protection (institutional floor) and upside optionality (FDA approval). FDA denial or delay on June 30; negative clinical or safety readouts; broader biotech selloff; dilution risk from the convertible notes (conversion at $24.65).
VRDN
Viridian Therapeutics, Inc.
Long
1ST
—
—
About VRDN Investor Commentary
Across the available history and selected sources, Buzzberg tracks VRDN (Viridian Therapeutics, Inc.) across 3 sources: 1 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 17% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 6 total trade ideas tracked. Latest voices: u/Buy-NVDA.